Medication info

Acetraleth Extended-Release Tablet

Prescription medicationApproval withdrawn
Ingredient · strength
Acetaminophen›Strength being verifiedTramadol Hydrochloride›Strength being verified
Manufacturer / importer
Punglim Pharmaceutical Co., Ltd.
Appearance
Light yellow rectangular extended-release film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201900998 · Approved 2019.02.19

This product's status changed to Approval withdrawn on 2023.08.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who uses it
Adults
Adult dosage
Adults: Adjust the dose according to the patient's level of pain and response to treatment. An initial dose of 1 tablet is recommended. Thereafter, allow at least 12 hours between doses, and do not exceed 4 tablets per day. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, drowsiness, and other symptoms may occur during treatment; carefully monitor the patient's response and adjust treatment appropriately. Elderly patients: Administer the usual adult dose. However, when tramadol is administered orally to patients aged 75 years and older, the elimination half-life of tramadol increases by 17%; therefore, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, administration is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, administration is not recommended.

Ingredients

Manufacturer
Punglim Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • moderate to severe chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

Dosage and Administration

Adult dosage

Adults: Adjust the dose according to the patient's level of pain and response to treatment. An initial dose of 1 tablet is recommended. Thereafter, allow at least 12 hours between doses, and do not exceed 4 tablets per day. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, drowsiness, and other symptoms may occur during treatment; carefully monitor the patient's response and adjust treatment appropriately. Elderly patients: Administer the usual adult dose. However, when tramadol is administered orally to patients aged 75 years and older, the elimination half-life of tramadol increases by 17%; therefore, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, administration is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, administration is not recommended.

Precautions

This medicine may pose a risk of liver damage, so those who regularly drink more than three glasses of alcohol daily should consult a doctor or pharmacist before taking it. If a rash, itching, or blisters appear on the skin while taking this medication, discontinue use immediately and inform medical personnel. Caution is needed if there is a history of seizures or if medications that can trigger seizures are taken concurrently due to the risk of seizures. This medication may infrequently cause severe allergic reactions, so if symptoms such as shortness of breath, hives, or facial swelling occur, inform medical personnel immediately. Patients with severe respiratory diseases should be monitored in a hospital while using this medication due to the risk of respiratory depression. Using this medication with alcohol or sedatives may cause severe drowsiness, respiratory depression, or a state of unconsciousness, so concurrent use should be avoided or undertaken following a doctor's instructions. Patients with head injuries or brain diseases need to be cautious as this medication may increase intracranial pressure or worsen symptoms during use. This medication can cause physical and psychological dependence, so strict adherence to a doctor's instructions is required for long-term use. Patients with liver or kidney impairment must consult a doctor before taking this medication, as dosage adjustments may be necessary. This medication is not to be administered to children under 12 years of age and adolescents under 18 years who have undergone tonsillectomy or adenoidectomy. This medication can cause hyponatremia (reduced sodium concentration in the blood), so elderly patients or those with risk factors should be closely observed for symptoms. Pregnant or breastfeeding women must consult medical personnel before taking this medication; particularly breastfeeding mothers should either discontinue breastfeeding or follow medical advice while using this medication. Drowsiness or dizziness may occur when taking this medication, so caution is advised when driving or operating machinery. Do not exceed the recommended dosage, and be careful not to take this medication with other pain relievers, as sudden discontinuation may lead to withdrawal symptoms; dosage should be gradually reduced according to a doctor's guidance. Overdosing on this medication can lead to severe respiratory depression or liver damage, so strict adherence to the dosage is required, and in the event of overdose, seek emergency treatment immediately.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, asthenia, fatigue, flushing, chest pain, rigidity, syncope, withdrawal symptoms, hypertension, worsening hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremors, ataxia, convulsions, hypertonia, migraine, worsening of migraine, involuntary muscle contractions, sensory disturbances, confusion, dizziness, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, bloody stools, tongue swelling, decreased appetite, anxiety, confusion, euphoria, insomnia, irritability, drowsiness, forgetfulness, depersonalization, depression, drug abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thinking, anemia, dyspnea, proteinuria, urinary disorders, oliguria, urinary retention, pruritus, rash, sweating, urticaria, liver function abnormalities, weight loss, tinnitus, abnormal vision, chills, palmar erythema, rhinitis, nasopharyngitis, limb pain, arthralgia, muscle cramps, muscle weakness, myalgia, blurred vision, conjunctivitis, decreased immune response, sensory abnormalities, stupor, taste disturbances, involuntary muscle contractions, migraine, dark urine, anuria, urinary delay, incontinence, upper abdominal pain, peptic ulcer, belching, chest discomfort, facial edema, chills, fever, peripheral edema, asthenia, pallor, blood pressure fluctuations, cough, runny nose, hematuria, blood pressure increase, palpitations, irregular menstruation, breast cancer, injury, congestive heart failure, dizziness, confusion, speech disorder, loss of consciousness, recurrence of myocardial infarction, hypotension, confusion, multiple organ failure, anaphylaxis, intentional overdose, delirium, miosis, mydriasis, speech disorder, movement disorder, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, withdrawal symptoms, toxic skin necrosis, bronchospasm, Stevens-Johnson syndrome, serotonin syndrome, worsening of asthma, withdrawal symptoms, withdrawal symptoms, paralytic ileus, cholecystitis, abnormal renal function tests, gastrointestinal bleeding, hiccups, hypersalivation, gastrointestinal bleeding, cholecystitis, paralytic ileus, abnormal renal function tests, heartburn, acute gastritis, cold, upper respiratory tract infection, general weakness, motion sickness, transient ischemic attack, lethargy, memory impairment, lack of efficacy, facial flushing

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius. This will help to preserve the medication's efficacy and safety over time.

Appearance and packaging

Appearance

Light yellow rectangular extended-release film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.